The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Two recent studies published this week assess the low uptake of respiratory syncytial virus (RSV) vaccine among US veterans ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private ...

Winter is here, and with it come higher rates of respiratory illnesses. If you've been struck down recently with a sore ...

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV, ...

RSV vaccines for babies, older adults and pregnant people are in the works from several companies. Here's the latest data and information. Hotspots ranked Start the day smarter ☀️ Funniest cap ...

Sanofi is buying Vicebio for more than $1 billion, picking up an experimental vaccine targeting RSV and another respiratory bug.

RSV vaccines will be most effective at saving lives if given before infections climb, which happened unusually early last year. "Lives, hospitalizations, we could have a significant impact this year.

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.